Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma Registry.
Saved in:
| Title: | Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma Registry. |
|---|---|
| Authors: | Pfeffer PE; Barts Health NHS Trust, London, UK.; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Karaj J; Barts Health NHS Trust, London, UK., Brown T; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Burhan H; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Chaudhuri R; Gartnavel General Hospital and University of Glasgow, Glasgow, UK., Prior K; Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK., Siddiqui S; National Heart and Lung Institute, Imperial College, London, UK., Heaney L; Queen's University, Belfast, UK., Jackson DJ; School of Immunology and Microbial Sciences, King's College London, London, UK.; Guy's and St Thomas' NHS Trust, London, UK., Patel M; Derriford Hospital, Plymouth, UK., Patel PH; Royal Brompton Hospital, London, UK.; Imperial College, London, UK., Rupani H; University Southampton NHS Foundation Trust, Southampton, UK., Busby J; Centre for Public Health, Queen's University, Belfast, UK. |
| Source: | ERJ open research [ERJ Open Res] 2026 Jan 19; Vol. 12 (1). Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
